China Medical Technologies, Inc. (the "Company") is a China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic ("IVD") products using Enhanced Chemiluminescence ("ECLIA") technology, Fluorescent in situ Hybridization ("FISH") technology, and Surface Plasmon Resonance (“SPR”) technology to detect and monitor various diseases and disorders.
BEIJING, Nov. 19 /PRNewswire-Asia-FirstCall/ -- China Medical
Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based
medical device company that develops, manufactures and markets advanced
in-vitro diagnostic products, today announced its unaudited financial results
for the second fiscal quarter ended September 30, 2009 ("2Q FY2009"). The
Company's 2009 fiscal year ends on March 31, 2010 ("FY2009").
2Q FY2009 Highlights
-- Revenues decreased by 14.4% y...
BEIJING, Nov. 17 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,
Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device
company that develops, manufactures and markets advanced in-vitro diagnostic
products, today announced shareholder resolution adopted at its annual general
meeting of shareholders held in Beijing on November 16, 2009.
At the annual general meeting, the Company's shareholders approved the
China Medical Technologies, Inc. 2009 Equity ...
BEIJING, Nov. 9 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,
Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device
company that develops, manufactures and markets advanced in-vitro diagnostic
products, today announced that the Company has received approval for its
Leukemia BCR/ABL fusion gene detection FISH Probe (the "Leukemia BCR/ABL FISH
Probe") from the State Food and Drug Administration of China (the "SFDA").
The Leukemia BCR/ABL FISH Probe ...
BEIJING, Nov. 2 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,
Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device
company that develops, manufactures and markets advanced in-vitro diagnostic
products, today announced that it will report its unaudited financial results
for the second fiscal quarter ended September 30, 2009 ("2Q FY2009") before
the U.S. market opens on November 19, 2009. The Company's 2009 fiscal year
ends on March 31, 2010.
The...
Stock Quote
November 2009
?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Sign up to receive e-mail alerts whenever China Medical Technologies, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
